BioFocus
DPI signed a €2.8 million (about $4.12 million) drug discovery contract with
Schering-Plough Research Institute (SPRI). The one-year collaboration will involve BioFocus DPI carrying out
medicinal chemistry and supporting biology and ADME/PK services for multiple Schering-Plough drug discovery projects at two of SPRI’s European sites. The deal builds on a partnership that was established between the companies in May 2009 and expanded in September.